|
Dr. Andrea Persaud is a BOARD CERTIFIED DERMATOLOGIST and Diplomate of the American Board of Dermatology, who practices both medical and cosmetic dermatology in New York City.
Dr. Persaud is Clinical Assistant Professor of Dermatology at New York University School of Medicine. She completed her residency in dermatology at the Mount Sinai School of Medicine, New York University. She received her MD degree at the Mount Sinai School of Medicine, and completed her medical internship at NYU/Bellevue Hospital of New York University.
Dr. Persaud has extensive research experience in dermatopharmacology, conducting
over 100 clinical trials. Dr. Persaud holds several fellowships in
dermatopharmacology in the Department of Dermatology at the Mount Sinai
School of Medicine and Ronald O. Perelman Department of Dermatology,
New York University School of Medicine. One of her widely recognized
work on treating pre-cancerous skin lesions (actinic keratoses) with
a topical immunomodulator (imiquimod cream) was approved by the
FDA.
|
|
|
Dr. Persaud has spoken at conferences nationally and internationally,
and is often quoted in the media and newsletters about her work on
treating pre-cancerous skin lesions with a topical immunomodulator
cream. Widely published in many medical journals, Dr. Persaud has also
published and presented more than 30 clinical research and case report
abstracts at various medical conferences and in journals. She has also
written a book chapter on psoriasis. She regularly attends American
Academy of Dermatology conferences and other dermatology meetings, and
serves as a reviewer for various dermatological journals and books.
Dr. Persaud is an active member of the National Psoriasis Foundation.
Dr. Persaud is also co-founder of Yauvan Professional Skin Care and serves
as the Vice-President of Yauvan Corporation.
Dr. Persaud's biography is listed in Who's Who in the World, Who's Who in America , and Who's Who in American Women, Who's Who in Medicine and Healthcare and Who's Who of Emerging Leaders..
Dr. Persaud in Media and Newsletters
Live at Five News on Channel 7: Topical Tacrolimus
in Atopic Dermatitis. June 2001. Andrea N. Persaud, M.D.
EyeWitness News on channel 7: Topical Tacrolimus in
Atopic Dermatitis. In 2000. Andrea N. Persaud, M.D.
Video Interview: Tacrolimus (Protopic Ointment) for
the treatment of pruritus/atopic dermatitis. Fujisawa Healthcare,
Feb 2000. Andrea N. Persaud, M.D.
National Psoriasis Foundation: Psoriasis Forum. Management
of Pustular Psoriasis. Fall 1999, Vol 5, No.3.
Andrea N.
Persaud, M.D. and Mark Lebwohl, M.D.
Skin & Allergy News: Media Coverage of Vitamin E Modulation
of Retinoid Toxicity. February 1999, Vol.30, No.2.
Andrea
N. Persaud, M.D.
The Oclassen Dermatology New Media Project: Topical
Therapies for Psoriasis. Access through American Academy of
Dermatology Website. Andrea N. Persaud, M.D. and Mark Lebwohl,
M.D.
Publications
1. Saladi RN, Cohen SR, Phelps RG, Persaud AN, Rudikoff
D.
Diltiazem induces severe photodistributed hyperpigmentation.
Case series, histo-immunopathology, management and review of
the literature.Archives of Dermatology. In Press.
2. Saladi RN, Smith E, Persaud AN.
Mustard: A potential agent of chemical warfare and terrorism.
Clinical and Experimental Dermatology. In Press.
3. Saladi RN, Persaud AN.
The causes of Skin Cancer – A comprehensive Review.
Drugs
of Today. 2005; 41(1):37-53.
4. Saladi RN, Persaud AN, Phelps RG, Cohen SR.
Scrotal calcinosis: Is the cause still unknown?.
Journal
of American Academy of Dermatolology. 2004; 51(2 Suppl):S97-S101.
5. Saladi RN, Persaud AN, Rudikoff D, Cohen SR.
Idiopathic splinter hemorrhages. Journal of American Academy
of Dermatolology. 2004; 50 (2):289-92
6. Persaud AN, Shamuelova E, Sherer D, Lou W, Singer G, Cervera C,
Lamba S, Lebwohl MG.
Clinical effect of imiquimod 5% cream in the treatment of actinic
keratosis. Journal of American Academy of Dermatolology.
2002; 47(4):553-6.
7. Persaud AN, Lebwohl M.
Imiquimod cream in the treatment of actinic keratoses.
Journal
of the American Academy of Dermatolology. 2002; 47:S236-9.
8. Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW,
Persaud AN, Lebwohl M.
Successful treatment of acne vulgaris using a new method: results
of a randomized vehicle-controlled trial of short-contact therapy
with 0.1% tazarotene gel. Archives of Dermatology. 2002;
138(4):481-9.
Abstracts Published and Presented
More than 25 Clinical Research and Case Report Abstracts has
been presented in National and International Conferences and
were published in various Journals.
Books and Book Chapters
Andrea N. Persaud, M.D., and Mark Lebwohl, M.D.: Psoriasis.
Current Practice of Medicine, Vol. 3, No.3 (March 2000), Dermatology
Section.
Invited Lectures and Presentations
Dermatoses of Pregnancy- Mount Sinai Medical Center. Department
of OB/GYN. (March 2004)
Effect of Imiquimod 5% cream in the Treatment of Actinic Keratoses.
14th Annual Conrad Stritzler Memorial Resident Competition.
The Dermatologic Society of Greater New York. New York. (Jan
2003)
Young Leader in Dermatology Conference. (Oct 2002)
Effect of Imiquimod 5% cream in the Treatment of Actinic Keratoses.
19th World Congress of Dermatology, Zurich, Switzerland. (July
2001)
Effect of Imiquimod 5% cream in the Treatment of Actinic Keratoses.
3nd Annual Mount Sinai Winter Symposium. Advances in Medical
and Surgical Dermatology. (Dec 2000)
The use of LFA3TIP Fusion protein (Amevive) in the Treatment
of Psoriasis. NYU Department of Dermatology CME Clinical Conference.
(April 1999)
Vitamin E Modulation of Retinoid Toxicity. Annual Advances in
Dermatology Conference, NYU Medical Center. (Oct 1998)
Use of LG1069 (Targretin): A novel Synthetic Retinoid in the
Treatment of Cutaneous T-Cell lymphoma. NYU Department of Dermatology
CME Clinical Conference. (April 1998)
Other Professional Activities
Professional Conferences
Regular Attendee of American Academy of Dermatology conferences and other Dermatology Meetings.
Reviewer of Journals
Journal of American Academy of Dermatology
American Journal of Clinical Dermatology
Reviewed Books
Ob/Gyn Dermatoses
|
